Acute respiratory distress due to antipsychotic drugs.
Yagmur
F
F
Ulusoy
H B
HB
Buyukoglan
H
H
Kaya
M G
MG
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000009:adverse effects; D004421:Dystonia / Q000139:chemically induced; D017809:Fatal Outcome; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007830:Larynx / Q000187:drug effects; D008297:Male; D000077152:Olanzapine; D012128:Respiratory Distress Syndrome / Q000139:chemically induced*; D012131:Respiratory Insufficiency / Q000139:chemically induced*; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D006220:Haloperidol; D018967:Risperidone; D000077152:Olanzapine; D002746:Chlorpromazine